Search alternatives:
significant decrease » significantly increased (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
significant decrease » significantly increased (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
-
1221
-
1222
-
1223
-
1224
-
1225
-
1226
-
1227
-
1228
Characteristics of study participants in women according to frailty groups.
Published 2025Subjects: -
1229
-
1230
-
1231
The Laboratory Animal Flow Diagram.
Published 2025“…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
-
1232
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025“…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
-
1233
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025“…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
-
1234
The structures of T3 and Kylo-0603.
Published 2025“…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
-
1235
Synthesis process of Kylo-0603.
Published 2025“…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
-
1236
ESI-HRMS spectra for Kylo-0603.
Published 2025“…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
-
1237
-
1238
-
1239
-
1240